These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


158 related items for PubMed ID: 3898140

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Chemo-immunoprevention in superficial bladder cancer].
    Adolphs HD, Bastian HP.
    Urologe A; 1986 Jan; 25(1):51-4. PubMed ID: 3962045
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Treatment of superficial bladder cancer.
    Morales A.
    Can Med Assoc J; 1980 May 24; 122(10):1133-8. PubMed ID: 6770987
    [Abstract] [Full Text] [Related]

  • 26. Resume of selected studies of the National Bladder Cancer Collaborative Group A and new protocols.
    Prout GR, Kopp J.
    Prog Clin Biol Res; 1984 May 24; 162B():397-427. PubMed ID: 6438644
    [No Abstract] [Full Text] [Related]

  • 27. BCG immunotherapy in superficial cancer of the bladder.
    Levinson IP, van Blerk PJ.
    S Afr J Surg; 1985 Jun 24; 23(2):53-4. PubMed ID: 3895464
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Microdoses of BCG vaccine for prophylaxis in bladder cancer stage T1].
    Rivera P, Caffarena E, Cornejo H, Del Pino M, Fonerón A, Haemmersli J, Sepúlveda M, Ubilla A.
    Actas Urol Esp; 1993 Apr 24; 17(4):243-6. PubMed ID: 8342414
    [Abstract] [Full Text] [Related]

  • 31. Can intravesical bacillus Calmette-Guérin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trials.
    Han RF, Pan JG.
    Urology; 2006 Jun 24; 67(6):1216-23. PubMed ID: 16765182
    [Abstract] [Full Text] [Related]

  • 32. Chemoimmune prophylaxis of superficial bladder carcinoma with cyclophosphamide and BCG.
    Jaeger N, Adolphs HD, Vahlensieck W.
    Prog Clin Biol Res; 1989 Jun 24; 303():393-9. PubMed ID: 2780655
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Prophylactic effects of zhuling and BCG on postoperative recurrence of bladder cancer].
    Yang DA, Li SQ, Li XT.
    Zhonghua Wai Ke Za Zhi; 1994 Jul 24; 32(7):433-4. PubMed ID: 7842985
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Intravesical instillation in the treatment of superficial tumors of the bladder].
    Chopin DK.
    Prog Urol; 1998 Apr 24; 8(2):268-73. PubMed ID: 9615941
    [Abstract] [Full Text] [Related]

  • 38. Antibody responses to Bacillus Calmette-Guérin during immunotherapy in bladder cancer patients.
    Winters WD, Lamm DL.
    Cancer Res; 1981 Jul 24; 41(7):2672-6. PubMed ID: 7018669
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.